Filtern
Volltext vorhanden
- ja (45)
Gehört zur Bibliographie
- ja (45)
Erscheinungsjahr
- 2020 (45) (entfernen)
Dokumenttyp
Schlagworte
- Neuropathischer Schmerz (3)
- Parkinson-Krankheit (3)
- multiple sclerosis (3)
- small fiber neuropathy (3)
- Fabry disease (2)
- Polyneuropathie (2)
- Proprioception (2)
- autoimmune (2)
- brain (2)
- criteria (2)
- fibromyalgia syndrome (2)
- gait initiation (2)
- glial fate modulation (2)
- mortality (2)
- myelin (2)
- neurology (2)
- pain (2)
- transplantation (2)
- ALS mimic (1)
- Adaptive cell transfer (1)
- Age (1)
- Alter (1)
- Amplitude (1)
- Aneurysma (1)
- Autoimmun (1)
- Axon degeneration (1)
- Biomarker (1)
- Biopsie (1)
- C-reactive protein (1)
- CCS (1)
- Charcot–Marie–Tooth disease type 1A (1)
- Corneale confocale Mikroskopie (1)
- Cytokine (1)
- DYT1 (1)
- Donor lymphocytes (1)
- Dopamine (1)
- ET (1)
- El Escorial (1)
- Encephalitis (1)
- English version (1)
- Enzephalitis (1)
- Essentieller Tremor (1)
- Evoziertes Potenzial (1)
- F-18-FDG PET (1)
- Fabry genotype (1)
- Fabry phenotype (1)
- Fabry-associated pain (1)
- Fatigue (1)
- Gait initiation (1)
- Genetik (1)
- Genexpression (1)
- Guillain-Barre-Syndrome (1)
- Haut (1)
- Hautstanzbiopsie (1)
- IL-22 binding protein isoform (1)
- IL-4 (1)
- IL22RA2 (1)
- Intraepidermale Nervenfaserdichte (1)
- JCV (1)
- Konfokale Mikroskopie (1)
- LSVT-big therapy (1)
- Langerhans cells (1)
- Macrophages (1)
- Merkel cell density (1)
- Microglia (1)
- Mikroneurographie (1)
- Motor Control (1)
- Multiple Sklerose (1)
- Musikwahrnehmung (1)
- Myeloma (1)
- NETs (1)
- Nervenfaser (1)
- Neurodegeneration (1)
- Neuronal ceroid lipofuscinosis (1)
- Nicht-motorische Begleitsymptome (1)
- PET (1)
- PML (1)
- PNP (1)
- Pain questionnaire (1)
- Parkinson (1)
- Parkinson disease (1)
- Parkinson's Disease (1)
- Parkinson’s disease (1)
- Parkionson's disease (1)
- Pathomechanismus (1)
- Pointing error (1)
- Polyneuropathy (1)
- Prodigy (1)
- Propriozeption (1)
- Psychophysik (1)
- Quantitative sensorische Testung (1)
- Quantitativer sudomotorischer Axonreflextest (1)
- Rhythmusperzeption (1)
- STDT (1)
- Schmerz-assoziierte evozierte Potenziale (1)
- Sensorik <Neurophysiologie> (1)
- Small Fiber Neuropathie (1)
- Stiff-Person-Syndrom (1)
- Subarachnoidalblutung (1)
- T lymphocytes (1)
- TDMT (1)
- TIMP-1 (1)
- TOR1A (1)
- Tdp-43 (1)
- Temporal Discrimination Threshold (1)
- Training (1)
- Zeitwahrnehmung (1)
- accuracy (1)
- acute ischemic stroke (1)
- acute lymphoblastic leukaemia (1)
- alpha-synuclein (1)
- amyotrophic lateral sclerosis (1)
- anthropometric measurements (1)
- anti-Amphiphysin Antikörper (1)
- anti-amphiphysin antibodies (1)
- areas (1)
- autoantibodies (1)
- axon guidance molecules (1)
- axonal transcriptome (1)
- back pain (1)
- basal ganglia (1)
- base of support (1)
- behavioral disorders (1)
- binding (1)
- biomarker (1)
- biopsies (1)
- blood sedimentation (1)
- brain metabolic alterations (1)
- brain stem (1)
- care tempis (1)
- cerebellar tDCS (1)
- cerebellar vermis hypoplasia (1)
- cerebellum (1)
- children (1)
- circuitopathies (1)
- classification (1)
- clinical diagnosis (1)
- compensatory strategies (1)
- consolidation (1)
- corneal confocal microscopy (1)
- cutaneous innervation (1)
- cytokines (1)
- dementia (1)
- diagnosis (1)
- disease (1)
- dopamine (1)
- dystonia (1)
- epidermis (1)
- exercise (1)
- expression (1)
- fatigue (1)
- freezing of gait (1)
- fungal infection (1)
- galactomannan (1)
- gene expression (1)
- generalized cerebellar atrophy (1)
- giant cell arteritis (1)
- glycine receptor autoantibodies (1)
- guidelines (1)
- health behavior (1)
- hemoglobin (1)
- high contrast (1)
- hospitals (1)
- human neurons (1)
- immunohistochemistry (1)
- incidence (1)
- induced neural stem cells (1)
- inducible expression (1)
- infarction volume (1)
- inflammatory demyelinating polyradiculoneuropathy (1)
- internet-based intervention (1)
- intraepidermal nerve fibre density (1)
- ischemic stroke (1)
- just noticeable difference (JND) (1)
- locomotor adaptation (1)
- lyso‐Gb3 (1)
- mesenchymal stem cells (1)
- miRNA (1)
- miRNS (1)
- microRNA (1)
- motor neuron disease (1)
- muscle atrophy (1)
- musical syntax (1)
- musikalische Syntax (1)
- musk myasthenia gravis (1)
- mutation (1)
- nerve-fibers (1)
- neural stem cell (1)
- neural stem cells (1)
- neuroborreliosis (1)
- neurofascin (1)
- neuronal differentiation (1)
- neuronal stem cells (1)
- neuropathic pain (1)
- neutrophils (1)
- nicotinamide (1)
- oligodendroglia (1)
- online systems (1)
- ontactin 1 (1)
- opioid (1)
- opioids (1)
- outcomes (1)
- p57kip2 (1)
- parkinson's disease (1)
- pathophysilogical mechanisms (1)
- periperal nerve (1)
- physical activity (1)
- pilot project (1)
- postural control (1)
- progressive ataxia (1)
- psychophysics (1)
- quality (1)
- quality of life (1)
- regional heterogeneity (1)
- rehabilitation (1)
- reinnervation (1)
- reproducible outcome measure (1)
- resting tremor (1)
- rhythmperception (1)
- risk (1)
- secretome (1)
- siRNA (1)
- signal peptide (1)
- skin biopsy (1)
- skin cells (1)
- skin punch biopsy (1)
- small molecule (1)
- small-molecule Inhibitoren (1)
- small-molecule inhibitors (1)
- spinal cord (1)
- spinal cord injury (1)
- split-belt treadmill (1)
- stenosis (1)
- stimulation (1)
- stroke (1)
- substance-P (1)
- switch (1)
- synapse (1)
- synaptic vesicles (1)
- systematic review (1)
- thrombemboli (1)
- thrombolysis (1)
- time (1)
- time perception (1)
- torsinA (1)
- transmission electron microscopy (1)
- vertebrobasilar insufficiency (1)
- vertebrobasilar stroke (1)
- vertigo (1)
- walking (1)
- zeitliche Wahrnehmungsschwellen (1)
- α‐GalA 3D‐structure (1)
Institut
- Neurologische Klinik und Poliklinik (45) (entfernen)
Sonstige beteiligte Institutionen
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
(2020)
[\(^{18}\)F]fluorodeoxyglucose (FDG) PET and [\(^{123}\)I]metaiodobenzylguanidine (MIBG) scintigraphy may contribute to the differential diagnosis of neurodegenerative parkinsonism. To identify the superior method, we retrospectively evaluated 54 patients with suspected neurodegenerative parkinsonism, who were referred for FDG PET and MIBG scintigraphy. Two investigators visually assessed FDG PET scans using an ordinal 6-step score for disease-specific patterns of Lewy body diseases (LBD) or atypical parkinsonism (APS) and assigned the latter to the subgroups multiple system atrophy (MSA), progressive supranuclear palsy (PSP), or corticobasal syndrome. Regions-of-interest analysis on anterior planar MIBG images served to calculate the heart-to-mediastinum ratio. Movement disorder specialists blinded to imaging results established clinical follow-up diagnosis by means of guideline-derived case vignettes. Clinical follow-up (1.7 +/- 2.3 years) revealed the following diagnoses: n = 19 LBD (n = 17 Parkinson's disease [PD], n = 1 PD dementia, and n = 1 dementia with Lewy bodies), n = 31 APS (n = 28 MSA, n = 3 PSP), n = 3 non-neurodegenerative parkinsonism; n = 1 patient could not be diagnosed and was excluded. Receiver operating characteristic analyses for discriminating LBD vs. non-LBD revealed a larger area under the curve for FDG PET than for MIBG scintigraphy at statistical trend level for consensus rating (0.82 vs. 0.69, p = 0.06; significant for investigator #1: 0.83 vs. 0.69, p = 0.04). The analysis of PD vs. MSA showed a similar difference (0.82 vs. 0.69, p = 0.11; rater #1: 0.83 vs. 0.69, p = 0.07). Albeit the notable differences in diagnostic performance did not attain statistical significance, the authors consider this finding clinically relevant and suggest that FDG PET, which also allows for subgrouping of APS, should be preferred.
Background: Multimodal rehabilitation improves fatigue and mobility in persons with multiple sclerosis (PwMS). Effects are transient and may be conserved by internet-based physical activity promotion programs. Objective: Evaluate the effects of internet-based physical activity and exercise promotion on fatigue, quality of life, and gait in PwMS after inpatient rehabilitation. Methods: PwMS (Expanded Disability Status Scale (EDSS) ≤ 6.0, fatigue: Würzburg Fatigue Inventory for Multiple Sclerosis (WEIMuS) ≥ 32) were randomized into an intervention group (IG) or a control group (CG). After rehabilitation, IG received 3 months of internet-based physical activity promotion, while CG received no intervention. Primary outcome: self-reported fatigue (WEIMuS). Secondary outcomes: quality of life (Multiple Sclerosis Impact Scale 29, MSIS-29), gait (2min/10m walking test, Tinetti score). Measurements: beginning (T0) and end (T1) of inpatient rehabilitation, 3 (T2) and 6 (T3) months afterwards. Results: 64 of 84 PwMS were analyzed (IG: 34, CG: 30). After rehabilitation, fatigue decreased in both groups. At T2 and T3, fatigue increased again in CG but was improved in IG (p < 0.001). MSIS-29 improved in both groups at T1 but remained improved at T2 and T3 only in IG. Gait improvements were more pronounced in IG at T2. Conclusions: The study provides Class II evidence that the effects of rehabilitation on fatigue, quality of life, and gait can be maintained for 3–6 months with an internet-based physical activity and exercise promotion program.
Zeitliche Diskrimination somatosensorischer und kinästhetischer Stimuli wurde als neurophysiologisches Korrelat für propriozeptive Präzision postuliert und bei verschiedenen Bewegungsstörungen als pathologisch beschrieben. Ziel der Untersuchung war es, den Einfluss von Alter und Polyneuropathie auf die kinästhetische (TDMT) und taktile (STDT) zeitliche Wahrnehmungsschwelle sowie die propriozeptive Genauigkeit bei Zeigeversuchen systematisch zu untersuchen.
Hierfür wurden 54 gesunde Probanden und 25 Polyneuropathie-Patienten im Alter zwischen 30 und 76 Jahren untersucht. Die STDT-Messung erfolgte mit Oberflächenelektroden, die an der Zeigefingerspitze bzw. am Großzehengrundgelenk angebracht wurden. Die TDMT-Werte wurden mit Hilfe einer sterilen Nadelelektrode erfasst, welche in den Musculus flexor carpi radialis bzw. Musculus tibialis anterior inseriert wurde.
Die Daten zur Propriozeption wurden mit Hilfe eines Goniometers erhoben und beinhalteten dabei aktive Zeigeaufgaben (Zeigen auf eine LED, Nachahmung einer Bewegung anhand einer auf einem Computerbildschirm dargebotenen PFEIL-Darstellung unterschiedlicher Länge) und die Einschätzung der Position der jeweiligen Extremität nach passiver Bewegung (PASSIV). Die Messungen erfolgten jeweils ohne visuelle Rückmeldung. Die Zeigefehler (Abweichung von der Zielposition) bzw. Schätzfehler (Abweichung der geschätzten von der tatsächlichen Position nach passiver Auslenkung) wurden als Maß der propriozeptiven Präzision verwendet.
Die Ergebnisse der gesunden Probandengruppe zeigten, dass höheres Alter mit höheren STDT- und TDMT-Werten korrelierte. Die Polyneuropathie-Patienten erzielten in allen Bereichen (Diskriminationsschwellen und Propriozeptionsaufgaben) signifikant schlechtere Ergebnisse als die gesunde Kontrollgruppe.
Zusätzlich konnte eine statistisch signifikante positive Korrelation zwischen der propriozeptiven Präzision bei den aktiven Zeige-Aufgaben (LED und PFEIL) und den zeitlichen Diskriminationsschwellen (STDT und TDMT) gezeigt werden.
In Anbetracht dieser Ergebnisse sollten das Patienten-Alter und mögliche Störungen der peripheren Nervenleitung berücksichtigt werden, wenn STDT-und TDMT-Bestimmungen bei Patienten mit Bewegungsstörungen angewendet werden. Die Korrelation zwischen den Diskriminationsschwellen und der Performance bei aktiven Zeigeversuchen (PFEIL- und LED-Aufgabe) legt nahe, dass STDT und TDMT Indikatoren der propriozeptiven Funktion sein könnten. Es ist weitere Forschungsarbeit notwendig, um diese Beziehung exakt zu beleuchten. Im Falle einer Bestätigung der Befunde auch bei Patienten mit Bewegungsstörungen erscheint denkbar, dass sich STDT und TDMT als vergleichsweise leicht messbare und gut quantifizierbare Parameter der Propriozeption herausstellen mit Potenzial zur differenzialdiagnostischen Anwendung, möglicherweise aber auch als Surrogatparameter einer gezielten rehabilitativen Behandlung.
Background
Pain is an early symptom of Fabry disease (FD) and is characterized by a unique phenotype with mainly episodic acral and triggerable burning pain. Recently, we designed and validated the first pain questionnaire for adult FD patients in an interview and a self-administered version in German: the Wurzburg Fabry Pain Questionnaire (FPQ). We now report the validation of the English version of the self-administered FPQ (enFPQ).
Methods
After two forward-backward translations of the FPQ by native German and native English speakers, the enFPQ was applied at The Mark Holland Metabolic Unit, Manchester, UK for validation. Consecutive patients with genetically ascertained FD and current or previous FD pain underwent a face-to-face interview using the enFPQ. Two weeks later, patients filled in the self-administered enFPQ at home. The agreement between entries collected by supervised administration and self-administration of the enFPQ was assessed via Gwet's AC1-statistics (AC1) for nominal-scaled scores and intraclass correlation coefficient (ICC) for interval-scaled elements.
Results
Eighty-three FD patients underwent the face-to-face interview and 54 patients sent back a completed self-administered version of the enFPQ 2 weeks later. We found high agreement with a mean AC1-statistics of 0.725 for 55 items, and very high agreement with a mean ICC of 0.811 for 9 items.
Conclusions
We provide the validated English version of the FPQ for self-administration in adult FD patients. The enFPQ collects detailed information on the individual FD pain phenotype and thus builds a solid basis for better pain classification and treatment in patients with FD.
Deterioration of gait and alterations of physiological gait initiation contribute significantly to the burden of disease in Parkinson's disease. This paper systematically investigates disease-specific alterations during the postural phases of gait initiation and demonstrates the influence of dopaminergic networks by assessing levodopa mediated improvements in motor performance and correlation of motor behavior with loss of striatal and cortical dopaminergic neurons. Particular attention is given to known confounders such as initial stance and anthropometrics.
Gait Initiation in Parkinson’s Disease: Impact of Dopamine Depletion and Initial Stance Condition
(2020)
Postural instability, in particular at gait initiation (GI), and resulting falls are a major determinant of poor quality of life in subjects with Parkinson’s disease (PD). Still, the contribution of the basal ganglia and dopamine on the feedforward postural control associated with this motor task is poorly known. In addition, the influence of anthropometric measures (AM) and initial stance condition on GI has never been consistently assessed. The biomechanical resultants of anticipatory postural adjustments contributing to GI [imbalance (IMB), unloading (UNL), and stepping phase) were studied in 26 unmedicated subjects with idiopathic PD and in 27 healthy subjects. A subset of 13 patients was analyzed under standardized medication conditions and the striatal dopaminergic innervation was studied in 22 patients using FP-CIT and SPECT. People with PD showed a significant reduction in center of pressure (CoP) displacement and velocity during the IMB phase, reduced first step length and velocity, and decreased velocity and acceleration of the center of mass (CoM) at toe off of the stance foot. All these measurements correlated with the dopaminergic innervation of the putamen and substantially improved with levodopa. These results were not influenced by anthropometric parameters or by the initial stance condition. In contrast, most of the measurements of the UNL phase were influenced by the foot placement and did not correlate with putaminal dopaminergic innervation. Our results suggest a significant role of dopamine and the putamen particularly in the elaboration of the IMB phase of anticipatory postural adjustments and in the execution of the first step. The basal ganglia circuitry may contribute to defining the optimal referent body configuration for a proper initiation of gait and possibly gait adaptation to the environment.
Objective
Impairment of glycinergic neurotransmission leads to complex movement and behavioral disorders. Patients harboring glycine receptor autoantibodies suffer from stiff‐person syndrome or its severe variant progressive encephalomyelitis with rigidity and myoclonus. Enhanced receptor internalization was proposed as the common molecular mechanism upon autoantibody binding. Although functional impairment of glycine receptors following autoantibody binding has recently been investigated, it is still incompletely understood.
Methods
A cell‐based assay was used for positive sample evaluation. Glycine receptor function was assessed by electrophysiological recordings and radioligand binding assays. The in vivo passive transfer of patient autoantibodies was done using the zebrafish animal model.
Results
Glycine receptor function as assessed by glycine dose–response curves showed significantly decreased glycine potency in the presence of patient sera. Upon binding of autoantibodies from 2 patients, a decreased fraction of desensitized receptors was observed, whereas closing of the ion channel remained fast. The glycine receptor N‐terminal residues \(^{29}\)A to \(^{62}\)G were mapped as a common epitope of glycine receptor autoantibodies. An in vivo transfer into the zebrafish animal model generated a phenotype with disturbed escape behavior accompanied by a reduced number of glycine receptor clusters in the spinal cord of affected animals.
Interpretation
Autoantibodies against the extracellular domain mediate alterations of glycine receptor physiology. Moreover, our in vivo data demonstrate that the autoantibodies are a direct cause of the disease, because the transfer of human glycine receptor autoantibodies to zebrafish larvae generated impaired escape behavior in the animal model compatible with abnormal startle response in stiff‐person syndrome or progressive encephalitis with rigidity and myoclonus patients.
Apart from dedicated oligodendroglial progenitor cells, adult neural stem cells (aNSCs) can also give rise to new oligodendrocytes in the adult central nervous system (CNS). This process mainly confers myelinating glial cell replacement in pathological situations and can hence contribute to glial heterogeneity. Our previous studies demonstrated that the p57kip2 gene encodes an intrinsic regulator of glial fate acquisition and we here investigated to what degree its modulation can affect stem cell‐dependent oligodendrogenesis in different CNS environments. We therefore transplanted p57kip2 knockdown aNSCs into white and gray matter (WM and GM) regions of the mouse brain, into uninjured spinal cords as well as in the vicinity of spinal cord injuries and evaluated integration and differentiation in vivo. Our experiments revealed that under healthy conditions intrinsic suppression of p57kip2 as well as WM localization promote differentiation toward myelinating oligodendrocytes at the expense of astrocyte generation. Moreover, p57kip2 knockdown conferred a strong benefit on cell survival augmenting net oligodendrocyte generation. In the vicinity of hemisectioned spinal cords, the gene knockdown led to a similar induction of oligodendroglial features; however, newly generated oligodendrocytes appeared to suffer more from the hostile environment. This study contributes to our understanding of mechanisms of adult oligodendrogenesis and glial heterogeneity and further reveals critical factors when considering aNSC mediated cell replacement in injury and disease.
Ischemic stroke caused by thromboembolic occlusion of large cerebral arteries, such as the internal carotid (ICA) and/or the middle cerebral artery (MCA), is treated by mechanical thrombectomy (MT). MT allows salvage of the vessel-occluding thrombemboli, which most frequently originate from the left atrium or the left ventricle of the heart or from sites of plaque rupture within large arteries above the heart. Clot composition may influence the efficacy of (intravenous) thrombolysis and MT, respectively. We analyzed 37 human thrombemboli obtained from acute ischemic stroke patients during MT with special emphasis on histological staining of neutrophils and neutrophil extracellular traps (NETs). We found neutrophils as the main cellular component of cerebral thrombemboli but encountered considerable morphological heterogeneity. Neutrophils accumulated in the border region of fibrin-rich structures indicating possible interaction of neutrophils with distinct structural thrombembolus components. Web-like NETs were found in 35 of 37 thrombemboli in varying amounts. NETs were almost exclusively found within fibrin-rich areas. Importantly, stroke etiology, age and present oral anticoagulation was associated with morphological patterns and the amount of neutrophils. Correlation of histological data and imaging data revealed that relative Hounsfield units of cerebral thrombemboli positively correlated with the amount of red blood cells. In summary, our results demonstrate that neutrophils and NETs are substantial constituents of cerebral thrombemboli and contribute to their structural complexity.
DYT-TOR1A is the most common inherited dystonia caused by a three nucleotide (GAG) deletion (dE) in the TOR1A gene. Death early after birth and cortical anomalies of the full knockout in rodents underscore its developmental importance. We therefore explored the timed effects of TOR1A-wt and TOR1A-dE during differentiation in a human neural in vitro model. We used lentiviral tet-ON expression of TOR1A-wt and -dE in induced neural stem cells derived from healthy donors. Overexpression was induced during proliferation of neural precursors, during differentiation and after differentiation into mature neurons. Overexpression of both wildtype and mutated protein had no effect on the viability and cell number of neural precursors as well as mature neurons when initiated before or after differentiation. However, if induced during differentiation, overexpression of TOR1A-wt and -dE led to a pronounced reduction of mature neurons in a dose dependent manner. Our data underscores the importance of physiological expression levels of TOR1A as crucial for proper neuronal differentiation. We did not find evidence for a specific impact of the mutated TOR1A on neuronal maturation.